Sector: MedicalClarient, Inc. (NASDAQ: CLRT)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 168 |
Technical : | 288 |
Performance : | 55 |
Overall: | 194 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 229 |
Technical : | 168 |
Performance : | 47 |
Overall: | 150 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 227 |
Technical : | 202 |
Performance : | 52 |
Overall: | 186 |
Number of Stocks: | 306 |
Headlines
- Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
Nov 09, 2009 06:01 AM | CLRT, PJC
- Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
Nov 05, 2009 04:02 PM | CLRT, CSCX
- Clarient Reports 2009 Third Quarter; Nine Month Results
Nov 03, 2009 04:15 PM | CLRT
- Clarient to Release 2009 Third Quarter Financial Results on Tuesday, November 3rd
Oct 29, 2009 11:58 AM | CLRT
- Clarient to Present at William Blair Third Annual Emerging Growth Conference in New York City
Sep 29, 2009 06:01 AM | CLRT
- Clarient to Present at Upcoming Investment Conferences in New York City
Sep 01, 2009 06:01 AM | CLRT
- CombiMatrix: Array Of Sunshine In '09?
Jan 15, 2009 10:13 AM | ACTG, AIG, CBMX, CLRT, DNA, HDIX
- A New Emerging Diagnostics Index
Dec 26, 2008 11:32 AM | ABT, AFFX, CLRT, DNA, DXCM, HDIX
- YM BioSciences Announces Phase 2 Metastatic Colorectal Cancer Results for Nimotuzumab
Aug 05, 2008 01:07 PM | CLRT, YMI
- Nine Stocks Strike Back
Aug 05, 2008 11:19 AM | ABC, CLRT, CSK, PGTI, PSPT, SLRY
- Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
Oct 19, 2009 09:53 AM | ABT, CLRT, DGX, IART, PFE
- Safeguard Scientifics Announces Sale of 2.4 Million Additional Clarient Shares Pursuant to Overallotment Option
Sep 22, 2009 09:52 AM | CLRT, SFE
- Safeguard Scientifics Announces Second Quarter 2009 Financial Results
Aug 05, 2009 06:51 AM | CLRT, LLY, SFE
- Clarient to Present at Canaccord Adams 29th Annual Global Growth Conference on Wednesday, August 12th
Aug 05, 2009 06:01 AM | CLRT
- Clarient Reports Second Quarter Revenue Up 40 Percent ; New Molecular Tests and Increased Case Volume Continue to Drive Revenue Growth; First Net Income Reported; Revenue Guidance Increased
Aug 04, 2009 06:51 PM | CLRT, SFE
- Clarient Reports Second Quarter Revenue Up 40 Percent
Aug 04, 2009 04:15 PM | CLRT
- Clarient to Release 2009 Second Quarter Financial Results On Tuesday, August 4th
Jul 28, 2009 06:02 AM | CLRT
- Emerging Growth Equities, Ltd. Initiates Coverage of Clarient, Inc. With a Buy Rating and $4.50 Price Target
Jul 22, 2009 10:32 AM | CLRT
- Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient
Jul 14, 2009 09:35 AM | ABT, CLRT, DGX
- Clarient Set to Join Russell 3000 Index
Jun 29, 2009 07:09 AM | CLRT, SFE
- Form 4 CLARIENT, INC For: Nov 05 Filed by: SAFEGUARD SCIENTIFICS INC (10K)
Nov 05, 2009 04:29 PM
- Form 4 Daly David For: Nov 03 (10K)
Nov 04, 2009 01:26 PM
- Form 4 Daly David For: Oct 05 (10K)
Oct 05, 2009 07:47 PM
- Form 4 CLARIENT, INC For: Sep 18 Filed by: SAFEGUARD SCIENTIFICS INC (10K)
Sep 18, 2009 03:21 PM
- Form 4 Daly David For: Sep 03 (10K)
Sep 04, 2009 03:22 PM
- Form 4 WALLER GREGORY D For: May 13 (10K)
Aug 12, 2009 03:10 PM
- Form 4 Smith Dennis M Jr For: May 13 (10K)
Aug 12, 2009 03:07 PM
- Form 4 CLARIENT, INC For: Jul 30 Filed by: SAFEGUARD SCIENTIFICS INC (10K)
Jul 31, 2009 04:46 PM
- Form 4 Daly David For: Jul 13 (10K)
Jul 14, 2009 04:39 PM
- Form 4 LAMONT ANN H For: May 14 (10K)
May 15, 2009 05:28 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CLRT
|
Compare to S&P
|
| YTD |
44.17 %
|
19.09 %
|
| 4 Weeks |
-37.50 %
|
-37.83 %
|
| 12 Weeks |
-34.36 %
|
-38.40 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 33.33 %
|
|
EPS Growth in Last Year: -33.33 %
|
|
Sales Growth in Last Quarter: -9.71 %
|
|
Sales Growth in Last Quarter: 12.78 %
|
|
